Innovative Eyewear, Inc. (LUCY)
USD 5.55
(-7.65%)
USD 5.55
(-7.65%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 856.75 Thousand USD | 804.7% |
| 2022 | 94.7 Thousand USD | -65.63% |
| 2021 | 275.5 Thousand USD | 6719.33% |
| 2020 | 4040.00 USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1 Million USD | 9.03% |
| 2024 Q1 | 918.31 Thousand USD | 7.18% |
| 2023 FY | 856.75 Thousand USD | 804.7% |
| 2023 Q2 | 659.86 Thousand USD | -11.2% |
| 2023 Q1 | 743.08 Thousand USD | 684.66% |
| 2023 Q4 | 856.75 Thousand USD | 10.39% |
| 2023 Q3 | 776.13 Thousand USD | 17.62% |
| 2022 Q2 | 325.41 Thousand USD | 13.1% |
| 2022 Q1 | 287.71 Thousand USD | 4.43% |
| 2022 FY | 94.7 Thousand USD | -65.63% |
| 2022 Q4 | 94.7 Thousand USD | -77.61% |
| 2022 Q3 | 422.9 Thousand USD | 29.96% |
| 2021 Q2 | 180.59 Thousand USD | 0.0% |
| 2021 FY | 275.5 Thousand USD | 6719.33% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q4 | 275.5 Thousand USD | 628.2% |
| 2021 Q3 | 37.83 Thousand USD | -79.05% |
| 2020 Q4 | 4040.00 USD | 0.0% |
| 2020 FY | 4040.00 USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | 95.207% |
| AngioDynamics, Inc. | 60.61 Million USD | 98.587% |
| AtriCure, Inc. | 67.89 Million USD | 98.738% |
| Avinger, Inc. | 5.29 Million USD | 83.829% |
| Azenta, Inc. | 128.19 Million USD | 99.332% |
| BioLife Solutions, Inc. | 43.45 Million USD | 98.028% |
| The Cooper Companies, Inc. | 735.6 Million USD | 99.884% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | 83.034% |
| Femasys Inc. | 667.11 Thousand USD | -28.427% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | 96.534% |
| Hologic, Inc. | 679.8 Million USD | 99.874% |
| ICU Medical, Inc. | 709.36 Million USD | 99.879% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 99.93% |
| KORU Medical Systems, Inc. | 3.48 Million USD | 75.39% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 98.363% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | 0.0% |
| Masimo Corporation | 545 Million USD | 99.843% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | 47.023% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 99.718% |
| Nephros, Inc. | 2.47 Million USD | 65.313% |
| NovoCure Limited | 38.15 Million USD | 97.754% |
| NEXGEL, Inc. | 1.31 Million USD | 35.045% |
| NEXGEL, Inc. | 1.31 Million USD | 35.045% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | 93.687% |
| OraSure Technologies, Inc. | 47.61 Million USD | 98.201% |
| Pro-Dex, Inc. | 15.26 Million USD | 94.389% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -73.302% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | 70.128% |
| QuidelOrtho Corporation | 577.8 Million USD | 99.852% |
| Repligen Corporation | 202.32 Million USD | 99.577% |
| Sanara MedTech Inc. | 4.71 Million USD | 81.839% |
| STAAR Surgical Company | 35.13 Million USD | 97.561% |
| Sharps Technology, Inc. | 1.7 Million USD | 49.872% |
| Utah Medical Products, Inc. | 9.58 Million USD | 91.059% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 99.863% |
| Jin Medical International Ltd. | 5.05 Million USD | 83.045% |